The Centre for ChemoSensory Research (formerly a research centre of UNSW) has now "spun-out" into two companies: E-Nose Pty Ltd and Graham Bell and Associates Pty Ltd.
Your key contact for both companies and the publication ChemoSense is g.bell@atp.com.au. The logo and the name Centre for ChemoSensory Research are owned by the spin-off companies.
E-Nose Pty Ltd was founded in February 2003 by Dr. Graham Bell and six scientists who have pioneered research in smell and electronic noses. The company is owned by these founders and ATP-Innovations, an innovation company based at the Australian Technology Park (ATP), Sydney. The company has offices and a lab at the ATP.
E-Nose Pty Ltd currently employs four staff and several sub-contractors. It is governed by a Board and advised by a Technical Advisory Board. We have close contact with UNSW and University of Sydney.
We supply continuous, real-time measurement of odour or airborne chemicals (electronic noses or E-Noses). We reduce the worry and costs to factory operators of fines and litigation from EPAs and the Community.
Our devices work on-site, for immediate action, thereby removing the slow and expensive method of bagging air samples for later analysis at a remote lab. E-Noses have, up until now, been laboratory instruments measuring a wide range of chemicals. The Company's strategy is to tailor its robust, industrial-strength products to meet specific customer needs. This results in smaller, faster, more affordable devices and information processing, producing high customer satisfaction.
Sentinels
E-Nose Pty Ltd designs and makes industry-specific devices (with appropriate software) for continuous monitoring of environmental odour. Two systems have been developed for the red meat industry and the sewerage industry. Customers include four abattoirs and two sewage companies (at mid-2005).
Smell Diagnostics (volatile chemical classification)
A diagnostic system for animal health is under development for The Australian Sheep CRC. Further research is progressing on diagnosis of diseases on the breath of humans. Projects are underway with clinical approval and the collaboration of appropriate expert clinicians, in the fields of diabetes and the early diagnosis of lung cancer. These studies will underpin intellectual property for future devices in the human health domain.
Process Control
Electronic noses can be used to control equipment such as odour abatement infrastructure, to help reduce costs and make it more effective.
A control device for large building air conditioning is in development. It is anticipated that monitoring and
process control devices will be applied in many of the same industrial settings.
E-nose offers a cost-effective, reliable and robust odour monitoring service for companies with environmental odour issues. E-Nose offers relief from environmental risk. It provides a site-customised system that facilitates real-time and predictive measurements to enhance odour management. The result is cost savings and reduction of pressures from the community and regulatory bodies. The E-Nose solution offers plant operators useful information with which to run their operations more effectively and at lower cost.
In the area of animal health, rapid assessment of animals for a variety of health conditions offers several benefits to the farmer, the animal and the environment. It will save the farmer time, allow targeted attention to specific animals and reduce unnecessary use of medicines and effort. Diagnosis of human health from the breath will be non-invasive, safe, relatively cheap and rapid. It will save time and money, and mitigate considerable risk to the patient. The potential markets in the human health field are huge.
E-Nose has a portfolio of patents for platform and specific applications. It owns all its IP outright. Further patentable IP is continously under development. The company is prepared to work with partners to create new technology and markets.
Regulatory authorities in all developed countries are requiring industries to measure and control their odour emissions. Our new technology meets this growing need, with continuous and real time systems, displacing current batch methods and providing enormous information power, for predicting and controlling odour. As the benefit to the consumer is peace of mind, enhanced corporate image, reduction of risks from prosecutions and cost savings in running odour abatement equipment, the outlook for e-nose technology business, globally, is extremely favourable. E-Nose Pty Ltd is positioned to take advantage of this outlook.
If you are interested in its products and services, or if you need advice on an odour issue, please call Graham Bell (+612 92094083) or e-mail g.bell@atp.com.au.